Laurel Wealth Advisors LLC Sells 150 Shares of Solventum Co. (NYSE:SOLV)

Laurel Wealth Advisors LLC trimmed its position in shares of Solventum Co. (NYSE:SOLV) by 20.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 591 shares of the company’s stock after selling 150 shares during the period. Laurel Wealth Advisors LLC’s holdings in Solventum were worth $39,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SOLV. Hollencrest Capital Management bought a new stake in shares of Solventum during the second quarter worth $25,000. Modus Advisors LLC purchased a new position in Solventum in the 4th quarter worth about $25,000. Copeland Capital Management LLC purchased a new position in Solventum in the 3rd quarter worth about $26,000. Mather Group LLC. bought a new stake in Solventum during the 3rd quarter valued at about $27,000. Finally, Twin Lakes Capital Management LLC purchased a new stake in Solventum in the 2nd quarter valued at about $29,000.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SOLV. Stifel Nicolaus began coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price on the stock. Wolfe Research started coverage on Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. Piper Sandler upped their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Morgan Stanley raised their price target on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Mizuho started coverage on shares of Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Solventum has an average rating of “Hold” and an average price target of $68.29.

Solventum Price Performance

Shares of NYSE SOLV opened at $72.00 on Thursday. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05. The business has a fifty day moving average price of $69.18 and a 200 day moving average price of $65.24. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.